Microbix Biosystems Inc. (TSX:MBX)
Canada · Delayed Price · Currency is CAD 0.2400
0.00 (0.00%)
At close: Feb 27, 2026
Microbix Biosystems Market Cap
Microbix Biosystems has a market cap or net worth of CAD 33.25 million as of March 2, 2026. Its market cap has decreased by -51.76% in one year.
Market Cap
33.25M
Enterprise Value
31.02M
Revenue
16.76M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.24
Market Cap Chart
Since October 1, 1992, Microbix Biosystems's market cap has increased from 13.38M to 33.25M, an increase of 148.49%. That is a compound annual growth rate of 2.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 33.25M | 4.02% |
| Dec 31, 2025 | 31.97M | -41.99% |
| Dec 31, 2024 | 55.10M | 3.47% |
| Dec 29, 2023 | 53.25M | -6.55% |
| Dec 30, 2022 | 56.99M | -47.62% |
| Dec 31, 2021 | 108.80M | 135.30% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NurExone Biologic | 62.62M |
| MedMira | 48.82M |
| Sernova Biotherapeutics | 47.47M |
| Devonian Health Group | 38.03M |
| BriaCell Therapeutics | 37.78M |
| Defence Therapeutics | 35.00M |
| Resverlogix | 34.73M |
| Telescope Innovations | 28.69M |